INVO Fertility, Inc.(IVF)

Medical - Devices · Sarasota, FL

$0.81-0.02 (-2.38%)

Delayed quote: Oct 6, 2026, 11:50 AM EDT

INVO Fertility (IVF) EBITDA Yield: History & Chart | TGMCharts

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T15:56:52.109Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:56:52.109Z.

Quote observation: 2026-10-06T15:50:36.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -5,366,924
Quote market capitalization: 1,445,438
Total debt · period ending 2026-06-30: 3,921,698
Cash · period ending 2026-06-30: 3,732,945

FMP input reference: 41cc49745c280c4d031fb4caf193e1584c396f81f9594ce119adf6f0846382c8

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

IVF EBITDA Yield Metrics

EBITDA YIELD

N/A

IVF Competitors' EBITDA Yield

IVF

INVO Fertility, Inc.

Current

Market Cap

$1.45M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELAB

PMGC Holdings Inc.

vs IVF

Market Cap

$1.47M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRIS

Curis, Inc.

vs IVF

Market Cap

$1.48M

EBITDA Yield

N/A

TTM Avg

0.69%

3Y Avg

0.69%

5Y Avg

0.69%

NXGL

NEXGEL, Inc.

vs IVF

Market Cap

$1.40M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs IVF

Market Cap

$1.40M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs IVF

Market Cap

$1.50M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NCEL

NewcelX Ltd.

vs IVF

Market Cap

$1.39M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNPX

Genprex, Inc.

vs IVF

Market Cap

$1.37M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PPCB

Propanc Biopharma, Inc.

vs IVF

Market Cap

$1.16M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMCC

IM Cannabis Corp.

vs IVF

Market Cap

$1.14M

EBITDA Yield

N/A

TTM Avg

8.30%

3Y Avg

8.30%

5Y Avg

8.30%

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
INVO Fertility, Inc. (IVF)	$1.45M	N/A	N/A	N/A	N/A
PMGC Holdings Inc. (ELAB)vs ›	$1.47M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.48M	N/A	0.69%	0.69%	0.69%
NEXGEL, Inc. (NXGL)vs ›	$1.40M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.40M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.50M	N/A	N/A	N/A	N/A
NewcelX Ltd. (NCEL)vs ›	$1.39M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.37M	N/A	N/A	N/A	N/A
Propanc Biopharma, Inc. (PPCB)vs ›	$1.16M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.14M	N/A	8.30%	8.30%	8.30%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

IVF EBITDA Yield Metrics

IVF Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics